Veracyte Announces First Quarter 2026 Financial Results
Veracyte reported Q1 2026 revenue of $139.1 million, up 21% year-over-year, with testing revenue growing 26% to $135.1 million driven by 30% growth in Decipher sales. The company raised full-year 2026 revenue guidance to $582 million to $592 million and increased adjusted EBITDA margin guidance to greater than 26%, signaling confidence in continued expansion.
Key figures
- Eps
- 0.35
- Revenue
- 139100000
- Guidance
- 2026 total revenue $582M-$592M, raised from $570M-$582M; Adjusted EBITDA margin >26%, raised from ~25%
- Revenue Yoy
- 21%
- Net income
- 28700000
- Adjusted ebitda
- 42800000
- Testing revenue
- 135100000
- Operating cash flow
- 35200000
- Testing revenue yoy
- 26%
- Cash and equivalents
- 439100000
- Adjusted ebitda margin
- 30.8%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.